Home » Topics » Substance use and poisoning, BioWorld Science

Substance use and poisoning, BioWorld Science
RSS

Alkermes reports results from clinical trials of ALKS-33

Oct. 14, 2009

Catalyst to continue development of vigabatrin for cocaine and methamphetamine addiction

Oct. 5, 2009

NIH awards Novelos Therapeutics and MGH grant to study NOV-002 and NOV-205

Oct. 2, 2009

NIAID awards Cleveland BioLabs grant for protectan CBLB-502 research

Sep. 29, 2009

RX-100 shows potential in protecting against lethal whole-body radiation

Sep. 18, 2009

Aeolus initiates second AEOL-10150 study as a countermeasure to radiation

Sep. 17, 2009

Aeolus commences study of AEOL-10150 as a countermeasure to radiation

Sep. 10, 2009

Lilly describes kappa opioid receptor antagonists for the treatment of ethanol use disorders

Sep. 2, 2009

Carisbamate suppresses alcohol intake in rat model of alcoholism

Aug. 27, 2009

Riluzole modulates alcohol self-administration and withdrawal in preclinical studies

Aug. 26, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 15, 2026.
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
Enliven’s phase I CML data Enable phase III with BCR/ABL1 bid
BioWorld
Tolerability is a key factor in the appeal of Enliven Therapeutics Inc.’s ELVN-001 for previously treated chronic myeloid leukemia (CML), which yielded positive...